Tien Liang BioTech Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
August 09, 2023
Share
Tien Liang BioTech Co., Ltd. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was TWD 109.98 million compared to TWD 123.77 million a year ago. Net income was TWD 5.47 million compared to TWD 10.05 million a year ago. Basic earnings per share from continuing operations was TWD 0.12 compared to TWD 0.22 a year ago. Diluted earnings per share from continuing operations was TWD 0.12 compared to TWD 0.22 a year ago.
For the six months, sales was TWD 235.08 million compared to TWD 273.13 million a year ago. Net income was TWD 11.96 million compared to TWD 34.96 million a year ago. Basic earnings per share from continuing operations was TWD 0.26 compared to TWD 0.76 a year ago. Diluted earnings per share from continuing operations was TWD 0.26 compared to TWD 0.76 a year ago.
Tien Liang BioTech Co., Ltd. is a Taiwan-based company principally engaged in the manufacture, wholesale and retail of health food products. The Company is also involved in the import, wholesale and retail of western medicines, as well as the manufacture and sales of traditional Chinese medicines. The Company also provides active pharmaceutical ingredients (APIs), biopharmaceuticals and others. The Company distributes its products in domestic market.